Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aluminium compounds as adjuvants for vaccines and toxoids in man: a review.

Literature DB >> 5329166

Aluminium compounds as adjuvants for vaccines and toxoids in man: a review.

M A Aprile, A C Wardlaw.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1966 PMID： 5329166

Source DB: PubMed Journal: Can J Public Health ISSN： 0008-4263

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. The importance of surface charge in the optimization of antigen-adjuvant interactions.

Authors: P M Callahan; A L Shorter; S L Hem
Journal: Pharm Res Date: 1991-07 Impact factor: 4.200

2. Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.

Authors: L F Fries; D M Gordon; R L Richards; J E Egan; M R Hollingdale; M Gross; C Silverman; C R Alving
Journal: Proc Natl Acad Sci U S A Date: 1992-01-01 Impact factor: 11.205

3. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum.

Authors: R P Weissburg; P W Berman; J L Cleland; D Eastman; F Farina; S Frie; A Lim; J Mordenti; T T Nguyen; M R Peterson
Journal: Pharm Res Date: 1995-10 Impact factor: 4.200

Review 4. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.

Authors: N Halsey; A Galazka
Journal: Bull World Health Organ Date: 1985 Impact factor: 9.408

5. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.

Authors: G S Hui; L Q Tam; S P Chang; S E Case; C Hashiro; W A Siddiqui; T Shiba; S Kusumoto; S Kotani
Journal: Infect Immun Date: 1991-05 Impact factor: 3.441

10. The early primary immune response to absorbed tetanus toxoid in man: A study of the influence of antigen concentration, carrier concentration, and sequence of dosage on the rate, extent, and persistence of the immune response to one and to two doses of toxoid.

Authors: R Maclennan; L Levine; K W Newell; G Edsall
Journal: Bull World Health Organ Date: 1973 Impact factor: 9.408

Aluminium compounds as adjuvants for vaccines and toxoids in man: a review.

1. The importance of surface charge in the optimization of antigen-adjuvant interactions.

2. Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.

3. Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum.

Review 4. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.

5. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.

6. Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.

7. Dextran sulphate: an adjuvant for cell-mediated immune responses.

8. A novel laser vaccine adjuvant increases the motility of antigen presenting cells.

9. Disparate adjuvant properties among three formulations of "alum".

10. The early primary immune response to absorbed tetanus toxoid in man: A study of the influence of antigen concentration, carrier concentration, and sequence of dosage on the rate, extent, and persistence of the immune response to one and to two doses of toxoid.